Involvement of nitric oxide and the ovarian blood follicle barrier in murine follicular cyst development

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1301-1308

  Nemade, Rashmi V ^a,c,f   Carrette, Odile ^a,d,g   Larsen, William J ^d   Markoff, Edith ^a,b,c,e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c Grad Program Molecular Biology   (United States)

^d Department of Cell Biology ^*

^e Division of Endocrinology   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g Unit 24 Rue Micheli du Crest   (Switzerland)

Author keywords

Blood follicle barrier; Follicular cyst; Nitric oxide; Ovary; Polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CUMULUS OOPHORUS; FOLLICLE CYST; GRANULOSA CELL; HORMONE ACTION; MOUSE; NONHUMAN; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL;

ANIMALS; BLOOD VESSELS; CHORIONIC GONADOTROPIN; ENZYME INHIBITORS; FEMALE; FOLLICULAR CYST; GRANULOSA CELLS; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVARIAN DISEASES; OVARIAN FOLLICLE; OVULATION; TESTOSTERONE;

EID: 0036901676     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04340-6     Document Type: Article

References (27)

1. Fraser C.M. Reproductive system. The Merck veterinary manual a handbook of diagnosis, therapy, and disease prevention and control for the veterinarian . 1998;977-1048 Merck & Co, Rahway, NJ.
2. Guzick D. Polycystic ovary syndrome symptomatology, pathophysiology, and epidemiology . Am J Obstet Gynecol. 179:1998;S89-93.
3. Erickson G, Yen S. The polycystic ovary syndrome. In: Adashi EY, Leung PCK, eds. The Ovary. New York: Raven Press, 1993:561-79.
4. Hefler L.A., Gregg A.R. Inducible and endothelial nitric oxide synthase genetic background affects ovulation in mice . Fertil Steril. 77:2002;147-151.
5. Agrawal R., Sladkevicius P., Engmann L., Conway G.S., Payne N.N., Bekis J., et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 13:1998;651-655.
6. Shukovski L., Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology. 135:1994;2287-2290.
7. Jablonka-Shariff A., Olson L.M. Hormonal regulation of nitric oxide synthases and their cell-specific expression during follicular development in the rat ovary. Endocrinology. 138:1997;460-468.
8. Hess K.A., Chen L., Larsen W.J. The ovarian blood follicle barrier is both charge- and size-selective in mice. Biol Reprod. 58:1998;705-711.
9. Powers R.W., Chen L., Russell P.T., Larsen W.J. Gonadotropin-stimulated regulation of blood-follicle barrier is mediated by nitric oxide. Am J Physiol. 269:1995;E290-298.
10. Chen L., Russell P.T., Larsen W.J. Sequential effects of follicle-stimulating hormone and luteinizing hormone on mouse cumulus expansion in vitro. Biol Reprod. 51:1994;290-295.
11. Anteby E.Y., Hurwitz A., Korach O., Revel A., Simon A., Finci-Yeheskel Z., et al. Human follicular nitric oxide pathway relationship to follicular size, oestradiol concentrations and ovarian blood flow . Hum Reprod. 11:1996;1947-1951.
12. Zaidi J., Campbell S., Pittrof R., Kyei-Mensah A., Shaker A., Jacobs H.S., et al. Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum Reprod. 10:1995;1992-1996.
13. Battaglia C., Artini P.G., Bencini S., Bianchi R., D'Ambrogio G., Genazzani A.R. Doppler analysis of uterine blood flow changes in spontaneous and medically induced menopause. Gynecol Endocrinol. 9:1995;143-148.
14. Risma K.A., Hirshfield A.N., Nilson J.H. Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology. 138:1997;3540-3547.
15. Chen L., Mao S.J., Larsen W.J. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J Biol Chem. 267:1992;12380-12386.
16. Chen L., Mao S.J., McLean L.R., Powers R.W., Larsen W.J. Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid. J Biol Chem. 269:1994;28282-28287.
17. Babal P., Pechanova O., Bernatova I. Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system. Physiol Res. 49:2000;47-54.
18. Pechanova O., Bernatova I., Babal P. Structural alterations in the heart after long-term L-NAME and D-NAME treatment. Gen Physiol Biophys. 18:(Suppl 1):1999;6-9.
19. Tan S.L., Zaidi J., Campbell S., Doyle P., Collins W. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle. Am J Obstet Gynecol. 175:1996;625-631.
20. Agrawal R., Conway G., Sladkevicius P., Tan S.L., Engmann L., Payne N., et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization relevance to ovarian hyperstimulation syndrome and polycystic ovaries . Fertil Steril. 70:1998;651-658.
21. Lees C., Jurkovic D., Zaidi J., Campbell S. Unexpected effect of a nitric oxide donor on uterine artery Doppler velocimetry in oligomenorrheic women with polycystic ovaries. Ultrasound Obstet Gynecol. 11:1998;129-132.
22. Heinonen M., Leppavuori A., Pyorala S. Evaluation of reproductive failure of female pigs based on slaughterhouse material and herd record survey. Anim Reprod Sci. 52:1998;235-244.
23. Rosenfield R.L. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynaecol. 11:1997;307-333.
24. Ibanez L., Potau N., Virdis R., Zampolli M., Terzi C., Gussinye M., et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood increased frequency of functional ovarian hyperandrogenism . J Clin Endocrinol Metab. 76:1993;1599-1603.
25. Garcia-Rudaz M.C., Ropelato M.G., Escobar M.E., Veldhuis J.D., Barontini M. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome. [published erratum appears in Eur J Endocrinol 1999 Nov;141(5):555] Eur J Endocrinol. 139:1998;621-630.
26. Avontuur J.A., Boomsma F., van den Meiracker A.H., de Jong F.H., Bruining H.A. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation. 99:1999;271-275.
27. Grover R., Zaccardelli D., Colice G., Guntupalli K., Watson D., Vincent J.L. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. [see comments] Crit Care Med. 27:1999;913-922.